Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,176

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,176 results for “ulcerative colitis”

Learn how ShareScore rates datasets ↗
zenodo40/100

Labeled Images for Ulcerative Colitis (LIMUC) Dataset

<h1><strong>Dataset Details</strong></h1> <p>The LIMUC dataset compromises 11276 images from 564 patients and 1043 colonoscopy procedures, who underwent colonoscopy for ulcerative colitis between December 2011 and July 2019 at the Department of Gastroenterology in Marmara University School of Medicine. Two experienced gastroenterologists blindly reviewed and classified all images according to the Mayo endoscopic score (MES). Images that were differently labeled by two reviewers were also labeled by a third experienced reviewer independently without seeing their previous labels. The final MES for differently labeled images was determined using majority voting.</p> <p><br><strong>Mayo 0:</strong> 6105 (54.14%)<br><strong>Mayo 1:</strong> 3052 (27.70%)<br><strong>Mayo 2:</strong> 1254 (11.12%)<br><strong>Mayo 3:</strong> 865 (7.67%)</p> <p><strong>patient_based_classified_images:</strong>&nbsp;Images of each patient are separated according to Mayo classes. If a train-val-test splitting is to be made according to the ratios desired by the user, this folder should be used.</p> <p><strong>train_and_validation_sets:</strong> Train and validation sets used in the <a href="https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izac226/6830946">research paper</a>. Using the scripts in dataset's GitHub repository, same 10-fold can be generated for replicating the results.</p> <p><strong>test_set:</strong> Test set used for performance measurement in the research paper. For a fair performance comparisons, this should be used to report performances.</p> <h1><strong>Suggested Metrics</strong></h1> <p>Since there are imbalances and ordinality among classes (Mayo-0, Mayo-1, Mayo-2, Mayo-3), quadratic weighted kappa (QWK) can be used as the main performance metric.&nbsp;The QWK is one of the commonly used statistics for the assessment of agreement on an ordinal scale and it is one of the best singular performance metrics for this problem regarding class imbalances. Mean absolute error (MAE), macro F1 score,&nbsp;or macro accuracy can be used as&nbsp;alternative performance metrics.</p> <h1><strong>LIMUC Code Repository</strong></h1> <p>Many scripts for preprocessing, splitting, training, and validating the dataset are provided in <a href="https://github.com/GorkemP/labeled-images-for-ulcerative-colitis">this</a> GitHub&nbsp;repository.</p> <h1><strong>Terms and Conditions</strong></h1> <p>The LIMUC dataset is licensed under the <strong>Creative Commons Attribution 4.0 International (CC BY 4.0)</strong> license. This license permits unrestricted use, distribution, and reproduction in any medium, provided that proper attribution is given to the original creators. This ensures that the dataset can be used for both <strong>research and commercial applications</strong> while maintaining transparency and acknowledgment of the contributors.</p> <p>For more details about the license, please refer to: <a>Creative Commons Attribution 4.0 International License</a>.</p> <p>Regarding the questions, please contact <em><strong>polatgorkem@gmail.com.</strong></em></p>

opencc-by-4.0Mar 2022View details →
ClinicalTrials.gov40/100

Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

ClinicalTrials.gov study NCT02559713. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

ClinicalTrials.gov study NCT03824561. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

ClinicalTrials.gov study NCT02611830. IPD Sharing: YES. Countries: 31. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

ClinicalTrials.gov study NCT02620046. IPD Sharing: YES. Countries: 33. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

ClinicalTrials.gov study NCT00790933. IPD Sharing: YES. Countries: 10. Publications: 6.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

ClinicalTrials.gov study NCT02743806. IPD Sharing: YES. Countries: 18. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT03653026. IPD Sharing: YES. Countries: 44. Publications: 9.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

ClinicalTrials.gov study NCT02093663. IPD Sharing: YES. Countries: 7. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis

ClinicalTrials.gov study NCT01124149. IPD Sharing: YES. Countries: 15. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan

ClinicalTrials.gov study NCT04223479. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov40/100

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

ClinicalTrials.gov study NCT03029143. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

ClinicalTrials.gov study NCT03710486. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)

ClinicalTrials.gov study NCT01903252. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis

ClinicalTrials.gov study NCT03178669. IPD Sharing: NO. Countries: 10. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT05061446. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

ClinicalTrials.gov study NCT02136069. IPD Sharing: YES. Countries: 20. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

ClinicalTrials.gov study NCT01393405. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

ClinicalTrials.gov study NCT01458574. IPD Sharing: Not stated. Countries: 31. Publications: 34.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record